Skip to content.
You are here: » News » Vildagliptin with EDMF CTD

Vildagliptin with EDMF CTD

We are pleased to inform you that our Indian manufacturing partner Stereokem Pharmaceuticals Ltd. has finalized the European Drug Master File in CTD-format for API VILDAGLIPTIN (Antidiabetics).

Vildagliptin is produced under exclusive manufacturing agreement in the facilities of Srini Pharmaceuticals Ltd., India, which is MHRA, WHO-GMP, US FDA and TGA approved.

If you need any further explanations, price indications, analytical samples etc. please let us know - we will try to help you in any case. The applicant's part of the EDMF CTD can be handed out against Secrecy Agreement.

Looking forward to hearing from you.

Your F. & A. PHARMA team

Back to News

F. & A. PHARMA-Handels-GmbH
Registered Office: Bonhoefferring 41, D - 46286 Dorsten, Germany
Phone: +49(0)2369-9261947, Fax: +49(0)2369-9261950
Corporate Office: Weserstrasse 4, D - 45768 Marl, Germany
Phone: +49(0)2365-910640, Fax: +49(0)2365-910641